Recorded fact · drug.label_indication
drug.label_indication for capivasertib|breast-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 487601e6 resolves to.
The record
| Fact id | 487601e601f78b0adc57cb2c |
|---|---|
| Entity | drug: capivasertib|breast-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260612 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
HR positive, HER2 negative locally advanced or metastatic breast cancer • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or m
Shown with dashes as hyphens. SHA-256 of the exact stored quote: eb245c138625dd7df3f3fcbd0897a375c0d9bb3a210c3110022d6d281a1e1a1f.
The value
{
"ingredient": "Capivasertib",
"conditionId": "breast-cancer",
"conditionName": "Breast Cancer",
"matchedAlias": "breast cancer",
"context": "indication",
"brand": "TRUQAP",
"identifiedVia": "product_elements",
"extractor": 5,
"labelSetId": "d698c106-2322-401e-b738-cbd83c843ecf",
"labelEffectiveTime": "20260612",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 2ac2d4f8106216312aea4bb51740e4082818af1c46c335c3dc62b21aa2e1c9f5.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.